Managing Treatment Side Effects — Staying Well Through Lung Cancer Therapy

The most common side effects depend on the treatment. Chemotherapy can cause nausea, fatigue, low blood counts, hair thinning, and tingling in the hands and feet. Chest radiation commonly causes tiredness, sore or difficult swallowing, and skin changes in the treated area. Immunotherapy can cause tiredness, rash, diarrhoea, and thyroid changes. Oral targeted (EGFR/ALK) tablets most often cause a skin rash and loose stools. Fatigue is the one side effect shared by nearly all treatments. Importantly, most of these are temporary and manageable, and supportive care is planned in advance to prevent or reduce them.

Chemo side effects management is largely preventive. Anti-nausea medicines are given before chemotherapy through the drip and continued at home, so severe vomiting is now uncommon. Blood is checked before each cycle, and if white cells are low a growth-factor injection or a short delay keeps you safe from infection. Hair thinning is temporary and regrows after treatment. Neuropathy (tingling in the hands and feet) should be reported early so the dose can be adjusted. Practical steps — small frequent meals, good hydration, gentle activity, and avoiding infection when counts are low — make a real difference. Always contact your team promptly for fever, uncontrolled vomiting, or diarrhoea.

Radiation side effects in the lung are mostly local and build up gradually over the treatment course. Tiredness is the most common and eases in the weeks after radiation ends. Because the food pipe often lies within the treatment area, many patients develop sore or difficult swallowing (radiation oesophagitis), managed with soothing rinses, pain relief, and a soft moist diet. Skin in the treated area can become pink, dry, or itchy. Less commonly, lung inflammation (radiation pneumonitis) develops weeks later, causing cough or breathlessness — this is treatable, which is why any new breathing symptom should be reported promptly. Modern techniques like IMRT and SBRT reduce these effects.

Yes, though immunotherapy is generally well tolerated. Because it works by activating the immune system, it can occasionally cause inflammation in any organ — most often the skin, bowel, thyroid, lungs, or liver. Common mild effects include tiredness, rash, and itching. More significant immune-related side effects, such as diarrhoea, cough, or breathlessness, can develop at any time, even after treatment finishes. The key is to report new symptoms early, because when caught early these effects are very treatable, often with steroid medicines. Your team will monitor blood tests and check in with you regularly to catch any immune-related effects quickly.

Oral targeted tablets for EGFR- or ALK-positive lung cancer avoid the hair loss and severe nausea of chemotherapy, but have their own pattern. The most common effects are an acne-like skin rash, dry skin and nail changes, loose stools or diarrhoea, and sometimes mouth sores. These are usually mild to moderate and respond well to supportive care — moisturisers, sun protection, prescribed creams for the skin, and anti-diarrhoeal measures for the gut. Importantly, do not stop or skip doses on your own when a side effect appears; speak to your oncologist first, as the side effect can almost always be managed while keeping the treatment working, with a dose adjustment if needed.

Fatigue is the most common side effect across all lung cancer treatments, and it is different from ordinary tiredness — rest alone may not fully relieve it. Helpful steps include gentle daily activity such as short walks (which research shows reduces cancer-related fatigue), pacing tasks with rest breaks, good nutrition and hydration, and protecting your sleep. If anaemia (low red blood cells) is contributing, treating it helps. Tell your team about fatigue rather than pushing through it silently — they can check for treatable causes and a psycho-oncologist or physiotherapist can help. Fatigue usually improves gradually once treatment finishes.

Contact your oncology team the same day for any of these: a fever of 100.4°F (38°C) or above, especially during chemotherapy; uncontrolled vomiting or diarrhoea, or being unable to keep fluids down; new or worsening breathlessness or chest pain; severe pain that is not controlled; yellowing of the eyes or skin; or any symptom that is rapidly getting worse. With immunotherapy in particular, reporting new symptoms early allows side effects to be treated before they become serious. A simple rule applies throughout treatment: when in doubt, call. It is always better to check than to wait.

Many can be reduced or prevented. Modern oncology treats side effects proactively rather than reactively. Anti-nausea medicine is given before chemotherapy, growth-factor injections can protect against dangerous drops in white blood cells, and a nutritionist can help protect your weight and strength before problems develop. Radiation is planned with precise techniques that spare healthy tissue. Targeted-therapy skin rash can be managed with skincare from the start. Not every side effect can be fully prevented, but planning ahead — which is the purpose of supportive care — substantially reduces how often and how severely they occur, and helps you complete treatment on schedule.

Usually not. Most side effects are managed with supportive care while treatment continues as planned. When a side effect is more significant, the more common responses are a short delay, a dose adjustment, or temporarily pausing one drug — not abandoning treatment altogether. The decision is always made by your oncology team based on the specific situation, and the aim is to keep you receiving the full benefit of treatment as safely as possible. This is exactly why side effects should be reported early: the earlier they are managed, the less likely they are to disrupt your treatment plan.

Yes. At CION, supportive (allied) care is part of the treatment plan, not an afterthought. A dedicated team — including a clinical nutritionist, a psycho-oncologist, and pain and symptom support — works alongside your medical, surgical, and radiation oncologists. Every lung cancer case is reviewed by a tumour board, so supportive care decisions are made by the whole team rather than one doctor. Every patient has a clear point of contact for managing side effects. The first consultation is free for cancer patients, and our care is available across our Hyderabad locations. You can book a consultation or request a callback using the form on this page.